Third Japanese University Shakes Finger at Novartis AG's Diovan Studies

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Shiga University of Medical Science on Thursday became the third Japanese institution to conclude that a clinical study report on Novartis Pharma K.K.’s Diovan blood pressure-lowering drug contained doubtful data and was inappropriate. A Novartis Pharma employee’s participation in the clinical study on the drug was problematic, said the university’s in-house committee investigating suspected manipulation of clinical data for the report. The Kyoto Prefectural University of Medicine and the Tokyo-based Jikei University School of Medicine earlier found that the employee had been involved in their respective studies on the drug and their reports, which have since been retracted, included manipulated data.

Help employers find you! Check out all the jobs and post your resume.

Back to news